Fred P.H.T.M. Romijn
Papers
1
Total Citations
46
H-Index
1
About
Fred P.H.T.M. Romijn is a leading figure in the field of clinical proteomics and mass spectrometry, whose work is driving a paradigm shift in precision diagnostics. His research focuses on bridging the gap between advanced analytical technologies and unmet clinical needs, particularly through the development of quantitative protein mass spectrometry (MS) tests. Romijn’s major contribution lies in championing the transition from traditional immunoassays to MS-based methods, which offer superior multiplexing capabilities and direct identification of proteoforms. His seminal 2021 paper, "The Time Has Come for Quantitative Protein Mass Spectrometry Tests That Target Unmet Clinical Needs," has garnered 46 citations and serves as a rallying cry for the field, arguing that MS is ideally suited for routine clinical measurement. By highlighting the limitations of indirect immunoassay readouts, Romijn has positioned MS as a transformative tool for precision diagnostics, enabling more accurate and comprehensive biomarker analysis. His work continues to influence both researchers and clinicians, paving the way for a new era of direct, multiplexed protein quantification in patient care.
Research Focus
Key Achievements
Top Papers
- 1